Robert Rottapel

机构：Ontario Institute for Cancer Research, University Health Network, University of Toronto, Princess Margaret Cancer Centre · ORCID：0000-0002-6024-5558

发表论文 347 篇 · 总被引 11360 次 · h-index 62

代表论文

Supplementary Table 1 from Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report (2026)
Table S6 from The FBXO45–GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis (2026)
Supplementary Figure S9 from Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report (2026)
Supplementary Figure S8 from Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report (2026)
Supplementary Figure S3 from Preclinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report (2026)
Figure S5 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion (2026)